(Q27002657)

English

Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis

scientific article

Statements

Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis (English)
0 references
0 references
0 references
Maiwenn Al
1 reference
Laura Burgers
1 reference
Marie Westwood
1 reference
Steve Ryder
1 reference
Martine Hoogendoorn
1 reference
Nigel Armstrong
1 reference
Alex Allen
1 reference
Hans Severens
1 reference
March 2014
1 reference
18
1 reference
18
1 reference
1-106
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit